Sotera Health Company
SHC
$11.13
-$0.53-4.55%
| Weiss Ratings | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.69 | |||
| Price History | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.02% | |||
| 30-Day Total Return | -17.43% | |||
| 60-Day Total Return | -18.64% | |||
| 90-Day Total Return | -22.22% | |||
| Year to Date Total Return | -18.28% | |||
| 1-Year Total Return | -4.87% | |||
| 2-Year Total Return | -35.59% | |||
| 3-Year Total Return | -49.68% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -31.09% | |||
| 52-Week Low % Change | 9.90% | |||
| Price | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $17.08 | |||
| 52-Week Low Price | $10.71 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Sep 09, 2024 | |||
| Valuation | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.34B | |||
| Enterprise Value | 5.41B | |||
| Price/Earnings (TTM) | 76.68 | |||
| Earnings Per Share (TTM) | 0.15 | |||
| Earnings Per Share Growth | -13.13% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.06 | |||
| Price/Book (Q) | 8.24 | |||
| Enterprise Value/Revenue (TTM) | 4.92 | |||
| Price | $11.13 | |||
| Enterprise Value/EBITDA (TTM) | 10.78 | |||
| Enterprise Value/EBIT | 16.12 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 285.82M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 440 262 1410 | |||
| Address | 9100 South Hills Blvd Broadview Heights, OH 44147 | |||
| Website | soterahealth.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 30.49% | |||
| Profit Margin | 4.03% | |||
| Management Effectiveness | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.76% | |||
| Return on Equity | 10.46% | |||
| Income Statement | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.10B | |||
| Total Revenue (TTM) | 1.10B | |||
| Revenue Per Share | $3.85 | |||
| Gross Profit (TTM) | 602.30M | |||
| EBITDA (TTM) | 501.84M | |||
| EBIT (TTM) | 335.56M | |||
| Net Income (TTM) | 44.40M | |||
| Net Income Avl. to Common (TTM) | 44.40M | |||
| Total Revenue Growth (Q YOY) | -6.46% | |||
| Earnings Growth (Q YOY) | -68.14% | |||
| EPS Diluted (TTM) | 0.15 | |||
| EPS Diluted Growth (Q YOY) | -68.18% | |||
| Balance Sheet | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 278.05M | |||
| Cash Per Share (Q) | $0.97 | |||
| Total Current Assets (Q) | 526.04M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 404.91M | |||
| Current Ratio (Q) | 2.754 | |||
| Book Value Per Share (Q) | $1.43 | |||
| Total Assets (Q) | 3.07B | |||
| Total Current Liabilities (Q) | 191.00M | |||
| Total Debt (Q) | 2.35B | |||
| Total Liabilities (Q) | 2.67B | |||
| Total Common Equity (Q) | 404.91M | |||
| Cash Flow | SHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -179.00M | |||
| Cash from Financing (TTM) | -50.56M | |||
| Net Change in Cash (TTM) | -22.79M | |||
| Levered Free Cash Flow (TTM) | 107.22M | |||
| Cash from Operations (TTM) | 224.16M | |||
